Studies have reported that the infiltration of T cells, especially CD4+ T cells and CD8+ T cells, into the tumor microenvironment (TME) demonstrate a good prognosis in cancers, such as breast, lung, melanoma, colorectal, brain, and cervical cancer [43,44,45,46]. This evidence concerns the gene CD4 and melanoma.